1-4 of 4
Manjunath Goolyam
Close
Sort by
Journal Articles

Effective Gene Therapy for Hemophilia a: Novel Re-Dosable Non-Viral Formulation That Provides Stable, and Durable FVIII Expression with Improved Tolerability

Brian Truong, Khal Hajj, Johannes Schwerk, Dongyang Zhang, Johnnatan Tamayo, Gizem Guzelsoy, Joseph Kubicki, Alicia Davis, Lijun Huang, Gopi Vemuri, Kevin Johnson, Dan Smith, Jordan Bendor, Mu Li, Manjunath Goolyam, Daniel Abernathy, Pranav Nyshadham, Fernando Espinoza, Michelle Burrascano, James Yen, Kevin Briseno, Min Tong, Jen Beck, Joseph Lucas, Pavan Battiprolu, Michael Bennett, Blair Madison, Brent Warner, Eric Ostertag, Joshua Rychak
Journal: Blood
Blood (2023) 142 (Supplement 1): 1232.
https://doi.org/10.1182/blood-2023-189784
Published: 2023
Journal Articles

A Spacer Sequence Inserted between the A1 and A2 Domains of Factor VIII Overcomes the Requirement for Proteolytic Cleavage at Arg 372 in the Generation of Cofactor Activity

Manjunath Goolyam Basavaraj, PhD, Sriram Krishnaswamy, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 21.
https://doi.org/10.1182/blood-2020-142522
Published: 2020
Journal Articles

A Novel Variant of Factor VIII Yields Cofactor Activity without Proteolysis between the A1 and A2 Domains

Manjunath Goolyam Basavaraj, PhD, Sriram Krishnaswamy, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3771.
https://doi.org/10.1182/blood-2018-99-116267
Published: 2018
Journal Articles

The Affinity of Factor X for the Intrinsic Xase Is Determined By Exosite Interactions Between the Substrate and the Enzyme Complex

Manjunath Goolyam Basavaraj, PhD, Sriram Krishnaswamy, PhD
Journal: Blood
Blood (2015) 126 (23): 1065.
https://doi.org/10.1182/blood.V126.23.1065.1065
Published: 2015